ROUSSELOT
Rousselot® Biomedical provides functional gelatin- and collagen-based biomaterials. By listening to our customers’ needs, we have developed tailor-made biomaterials for high-end biomedical applications that are currently on the market or in (pre-)clinical trials. Our biomaterials are customized for reliable and scalable medical devices and pharmaceuticals. And today, they are used in flowable hemostats, cell delivery vehicles, embolizing agents, tissue engineering, regenerative medicine, drug delivery systems, surgical adhesives, cancer screening, IVD, wound healing and organ on a chip. We can support your development at any stage and speed up your time to clinical trials by helping you choose the most suitable biomaterial for your application. Arrange a meeting to discuss your challenge. | Rousselot Biomedical provides functional collagen-based biomaterials. By listening to our customers’ needs, we have develop tailor-made biomaterials for high-end biomedical applications that are currently commercially available or in (pre-)clinical trials. Our biomaterials are customized for reliable and scalable medical devices and pharmaceuticals. And today, they are used in flowable hemostats, cell delivery vehicles, embolizing agents, tissue engineering, regenerative medicine, drug delivery systems, surgical adhesives, cancer screening, IVD, wound healing and organ on a chip. We can support your development at any stage and speed up your time to clinical trials by helping you choose the most suitable biomaterial for your application. Arrange a meeting to discuss your challenge. | Rousselot is the global leader of collagen-based solutions* for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global customer-base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health. Through our state-of-the-art operations, extensive technical expertise and sustained scientific research, we help our customers achieve their goals, create world-class products, and we “Reach further together”. Rousselot is Darling Ingredients’ health brand.
Ronawk, Inc.
Ronawk’s Bio-Blocks™ platform is a proprietary 3D bioprinted hydrogel system designed to replicate physiologic microenvironments with exceptional fidelity. It supports the growth and organization of over 80 cell types including primary cells, explants, and co-cultures, enabling tissue-mimetic architecture. Ronawk is advancing a pipeline that includes wound healing, regenerative medicine applications, and immune and stem cell expansion.
Roche
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.
Roche Diagnostics
Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple, and complete. | Roche provides innovative healthcare solutions focused on testing efficiency and medical value to face the challenges of today even as we anticipate the needs of tomorrow. Genentech, now a member of the Roche Group, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with life-threatening diseases.
Roche Sequencing Solutions, Inc.
Riverain Technologies
At Riverain, we are relentless innovators that empower healthcare providers by streamlining diagnostic processes, elevating detection accuracy, and improving the outcomes of patients with cardiothoracic diagnoses. As imaging volume continues to grow along with the demand for faster turnaround times and earlier diagnoses, tools that improve efficiency and accuracy are essential. ClearRead™ Chest is a cardiothoracic AI suite that reduces reading time and eases cognitive burden while improving accuracy. A series of advanced AI algorithms are deployed and provide key insights and metrics on pulmonary nodules and CAC. Findings and analysis are then integrated in the radiology report. ClearRead is a valuable additional to lung cancer screening programs or for incidental nodule detection and CAC quantification.
Rivanna Medical, Inc.
RIVANNA® is a commercial-stage medical device innovator and manufacturer in Charlottesville, VA. RIVANNA’s mission is to develop and commercialize world-first, imaging-based medical technologies that elevate global standards of care. The company provides comprehensive imaging solutions for early- and late-stage spinal needle interventions and fracture/soft-tissue diagnostics that offer enhanced precision, safety, and patient care while remaining cost-effective and versatile.
RhoDx
Powering the Future of Liquid Biopsy RhoDx is dedicated to unleashing the power of liquid biopsy to fight cancer. Our cell free DNA/RNA enrichment technologies deliver transformative improvements in performance and efficiency to ensure liquid biopsy will be an accessible and effective weapon against cancer. RhoDx’s PointSuppressor (PSP) suppresses wild-type DNA background before you sequence-delivering clearer mutant calls, higher detection sensitivity, and dramatically lower NGS costs. PointSuppressor doesn’t require blockers or allele-specific primers, and because the method stays single-tube, it integrates seamlessly with Lynx automation. No extra steps. No sample loss.
Rhode Island Life Science Hub & RI Bio Pavilion
Join us at the Bio 2025 Rhode Island Pavilion, a collaborative initiative by the Rhode Island Life Science Hub and RI Bio. This pavilion showcases Rhode Island’s dynamic life sciences sector, highlighting groundbreaking innovations and fostering partnerships among industry leaders, academic institutions, and healthcare organizations. Discover how Rhode Island is advancing biotechnology to improve lives and drive economic growth.
RHCNZ – Auckland, Bay, Pacific Radiology
We are New Zealand’s leading private radiology provider, dedicated to making world-class radiology services accessible to every person, in every community, enabling better health outcomes for all New Zealanders. Our nationwide network includes more than 160 specialist radiologists working throughout our 74+ clinics, across our three iconic brands – Auckland Radiology, Bay Radiology and Pacific Radiology.